Fig. 3From: Maternal and neonatal outcomes with the use of long acting, compared to intermediate acting basal insulin (NPH) for managing diabetes during pregnancy: a systematic review and meta-analysisMaternal gestational weight gain (Kg) and glycosylated haemoglobin (HbA1c, %) in women with gestational diabetes receiving long-acting insulin analogues (glargine and/or detemir), compared to intermediate acting neutral protamine HagedronBack to article page